109 related articles for article (PubMed ID: 2570971)
21. Treatment of premenstrual disorders by suppression of ovulation by transdermal estrogens.
Studd J
Menopause Int; 2012 Jun; 18(2):65-7. PubMed ID: 22611224
[TBL] [Abstract][Full Text] [Related]
22. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
23. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
24. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
25. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.
Valen-Sendstad A; Engedal K; Stray-Pedersen B; ; Strobel C; Barnett L; Meyer N; Nurminemi M
Am J Geriatr Psychiatry; 2010 Jan; 18(1):11-20. PubMed ID: 20094015
[TBL] [Abstract][Full Text] [Related]
26. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
[TBL] [Abstract][Full Text] [Related]
27. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
[TBL] [Abstract][Full Text] [Related]
28. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Brynhildsen J; Hammar M
Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
[TBL] [Abstract][Full Text] [Related]
29. No effect of vitamin B-6 against premenstrual tension. A controlled clinical study.
Hagen I; Nesheim BI; Tuntland T
Acta Obstet Gynecol Scand; 1985; 64(8):667-70. PubMed ID: 3914180
[TBL] [Abstract][Full Text] [Related]
30. Oral magnesium successfully relieves premenstrual mood changes.
Facchinetti F; Borella P; Sances G; Fioroni L; Nappi RE; Genazzani AR
Obstet Gynecol; 1991 Aug; 78(2):177-81. PubMed ID: 2067759
[TBL] [Abstract][Full Text] [Related]
31. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
32. The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy.
Leather AT; Studd JW; Watson NR; Holland EF
Obstet Gynecol; 1993 Jan; 81(1):104-7. PubMed ID: 8416441
[TBL] [Abstract][Full Text] [Related]
33. Postmenopausal bone loss: does HRT always work?
Stevenson JC; Hillard TC; Lees B; Whitcroft SI; Ellerington MC; Whitehead MI
Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():88-91. PubMed ID: 8252111
[TBL] [Abstract][Full Text] [Related]
34. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
Greenwald MW; Gluck OS; Lang E; Rakov V
Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
[TBL] [Abstract][Full Text] [Related]
35. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
[TBL] [Abstract][Full Text] [Related]
36. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
Freeman E; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
[TBL] [Abstract][Full Text] [Related]
37. Effects of a yeast-based dietary supplementation on premenstrual syndrome. A double-blind placebo-controlled study.
Facchinetti F; Nappi RE; Sances MG; Neri I; Grandinetti G; Genazzani A
Gynecol Obstet Invest; 1997; 43(2):120-4. PubMed ID: 9067720
[TBL] [Abstract][Full Text] [Related]
38. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
Limpaphayom KK; Bunyavejchevin S
J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
[TBL] [Abstract][Full Text] [Related]
39. Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life.
Borenstein J; Yu HT; Wade S; Chiou CF; Rapkin A
J Reprod Med; 2003 Feb; 48(2):79-85. PubMed ID: 12621790
[TBL] [Abstract][Full Text] [Related]
40. The effect of dydrogesterone on premenstrual symptoms. A double-blind, randomized, placebo-controlled study in general practice.
Hoffmann V; Pedersen PA; Philip J; Fly P; Pedersen C
Scand J Prim Health Care; 1988 Sep; 6(3):179-83. PubMed ID: 3065875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
